Loading clinical trials...
Loading clinical trials...
To evaluate safety, tolerability, pharmacokinetics and immunogenicity of CDP7657
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
UCB Pharma
NCT03922724 · Peripheral T-cell Lymphomas, Lymphoproliferative Disorders, and more
NCT07362654 · Celiac Disease, Gluten Sensitivity, and more
NCT02579967 · Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, and more
NCT07330245 · Lupus Erythematosus, Systemic
NCT06948110 · Autoimmune Diseases
6
Leuven
9
Sofia
1
Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions